Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population [Internet].

van Ballegooijen M, Habbema JDF, Boer R, Zauber AG, Brown ML.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 9.

2.

Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary.

Institute of Medicine (US), National Research Council (US); Pignone M, Russell L, Wagner J, editors.

Washington (DC): National Academies Press (US); 2005.

3.

Speaking for the evidence: colonoscopy vs computed tomographic colonography.

Harris R.

J Natl Cancer Inst. 2010 Aug 18;102(16):1212-4. doi: 10.1093/jnci/djq286. Epub 2010 Jul 22. No abstract available.

PMID:
20651321
4.

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators.

Lancet. 2010 May 8;375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X. Epub 2010 Apr 27.

5.

Survey of access to gastroenterology in Canada: the SAGE wait times program.

Leddin D, Bridges RJ, Morgan DG, Fallone C, Render C, Plourde V, Gray J, Switzer C, McHattie J, Singh H, Walli E, Murray I, Nestel A, Sinclair P, Chen Y, Irvine EJ.

Can J Gastroenterol. 2010 Jan;24(1):20-5.

6.

[Colorectal cancer screening: advice from the Health Council of the Netherlands].

van Veen W, Mali WP.

Ned Tijdschr Geneeskd. 2009;153:A1441. Dutch.

PMID:
20003552
7.

Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.

Haug U, Hundt S, Brenner H.

Am J Gastroenterol. 2010 Mar;105(3):682-90. doi: 10.1038/ajg.2009.668. Epub 2009 Dec 1.

PMID:
19953091
8.

Population-based screening for colorectal cancer: Australian research and implementation.

Young GP.

J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S33-42. doi: 10.1111/j.1440-1746.2009.06069.x. Review.

PMID:
19799696
9.

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ.

Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089.

PMID:
19671542
10.

Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance.

Subramanian S, Bobashev G, Morris RJ.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):1971-8. doi: 10.1158/1055-9965.EPI-09-0083. Epub 2009 Jun 30.

11.

Ireland's recommended colorectal cancer screening programme will not get extra government funding.

Houston M.

BMJ. 2009 Jun 23;338:b2551. doi: 10.1136/bmj.b2551. No abstract available.

PMID:
19549652
12.

The impact of national guidelines on the waiting list for colonoscopy: a quantitative clinical audit.

Chivers K, Basnyat P, Taffinder N.

Colorectal Dis. 2010 Jul;12(7):632-9. doi: 10.1111/j.1463-1318.2009.01871.x. Epub 2009 Apr 10.

PMID:
19486094
13.

At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JD.

Int J Cancer. 2009 Mar 1;124(5):1161-8. doi: 10.1002/ijc.24025.

14.

Population screening for colorectal cancer: the implications of an ageing population.

Macafee DA, Waller M, Whynes DK, Moss S, Scholefield JH.

Br J Cancer. 2008 Dec 16;99(12):1991-2000. doi: 10.1038/sj.bjc.6604788. Epub 2008 Nov 25.

15.

Stool DNA testing and colon cancer prevention: another step forward.

Chung DC.

Ann Intern Med. 2008 Oct 7;149(7):509-10. No abstract available.

PMID:
18838731
16.

Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.

17.

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM.

Ann Intern Med. 2008 Nov 4;149(9):659-69. Epub 2008 Oct 6.

18.

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Nov 4;149(9):627-37. Epub 2008 Oct 6.

PMID:
18838716
19.

A simplified, noninvasive stool DNA test for colorectal cancer detection.

Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM.

Am J Gastroenterol. 2008 Nov;103(11):2862-70. doi: 10.1111/j.1572-0241.2008.02088.x. Epub 2008 Aug 27.

PMID:
18759824
20.

Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

Tsoi KK, Ng SS, Leung MC, Sung JJ.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63. doi: 10.1111/j.1365-2036.2008.03726.x.

Supplemental Content

Support Center